Replimune Group, Inc.

By person

22 insiders · 278 transactions

14.4×

Sushil Patel holds 14.4 times base salary in stock. $10.11M of shares against $700.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Sushil Patel last reported holding, valued at $14.28, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Coffin Robert

Director

—

$21.06M (20)

−$21.06M

1,821,872

2.17%

$26.02M

−24.5%

Love Colin

Chief Operating Officer

—

$13.28M (43)

−$13.28M

777,345

0.9260%

$11.10M

−30.5%

Bain Capital Life Sciences Investors, LLC entity

10% owner

$7.50M (1)

—

+$7.50M

2,838,968

3.38%

$40.54M

—

Astley-Sparke Philip

Director

—

$6.90M (27)

−$6.90M

1,362,414

1.62%

$19.46M

−5.5%

Esposito Pamela

Chief Business Officer

—

$6.34M (21) scheduled

−$6.34M

263,436

0.3138%

$3.76M

—

Omega Fund IV, L.P. entity

10% owner

$6.99M (2)

$12.96M (30)

−$5.97M

9,436,760

11.24%

$134.76M

+98.0%

Rhodes Jason P

Director

$14.97M (1)

$17.66M (71)

−$2.69M

19,285

0.0230%

$275.39K

—

Franchi Jean M.

Chief Financial Officer

—

$2.01M (8) scheduled

−$2.01M

128,748

0.1534%

$1.84M

—

Forbion Capital Fund III Cooperatief U.A. entity

10% owner

$2.00M (1)

—

+$2.00M

4,721,449

5.62%

$67.42M

—

Slootweg Hugo Alexander

Director

$2.00M (1)

—

+$2.00M

4,721,449

5.62%

$67.42M

—

Dhingra Kapil

Director

—

$1.86M (4) scheduled

−$1.86M

0.0000%

$0.00

—

Patel Sushil

Chief Executive Officer

—

$1.84M (10)

−$1.84M

708,151

0.8436%

$10.11M

—

Xynos Konstantinos

Chief Medical Officer

—

$681.94K (9)

−$681.94K

224,215

0.2671%

$3.20M

+320.7%

Lewis Tanya

Chief Dev. Op. Officer

—

$609.58K (4) scheduled

−$609.58K

135,293

0.1612%

$1.93M

—

Hill Emily Luisa

Chief Financial Officer

—

$480.89K (6)

−$480.89K

215,852

0.2571%

$3.08M

—

Sarchi Christopher

Chief Commercial Officer

—

$412.20K (8)

−$412.20K

180,962

0.2156%

$2.58M

+133.5%

Schwendenman Andrew

Chief Accounting Officer

—

$180.42K (4)

−$180.42K

99,425

0.1184%

$1.42M

−38.9%

SLATTERY JOSEPH P

Director

$100.01K (1)

$239.20K (1) scheduled

−$139.20K

6,667

0.0079%

$95.20K

—

Atlas Venture Fund X, L.P. entity

10% owner

—

2,486,296

2.96%

$35.50M

—

Redmile Group, LLC entity

10% owner

—

779,655

0.9288%

$11.13M

—

Kaufman Howard

Chief Medical Officer

—

58,067

0.0692%

$829.20K

—

Pirzkall Andrea

Chief Medical Officer

—

21,500

0.0256%

$307.02K

+2,050%

By person

Individual transactions

What was left out